title: Transient Hyponatremia During Hospitalization for Acute Heart Failure.
abstract: The objective was to study whether the temporal pattern of transient hyponatremia development in acute heart failure might provide insight into its pathophysiology and prognostic relevance.
  
  
  
  A post hoc analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) and Diuretic Optimization Strategies Evaluation in Acute Heart Failure (DOSE AHF) studies was performed (n = 716). Patients were stratified according to the temporal pattern of hyponatremia development: (1) no hyponatremia, (2) persistent hyponatremia, (3) decompensation hyponatremia disappearing with decongestive treatment, and (4) treatment-induced hyponatremia.
  
  
  
  Transient decompensation versus no hyponatremia was associated with significantly elevated blood urea nitrogen/creatinine ratio (P < .001), plasma renin activity (P < .001), and plasma aldosterone levels (P < .001) at baseline. Disease severity characteristics of such patients were intermediate between no and persistent hyponatremia. In contrast, patients with treatment-induced versus no hyponatremia had similar baseline characteristics and comparable natriuretic peptide levels, and both groups had little neurohumoral activation at baseline. Diuretic efficacy, defined as net fluid balance (milliliters) per 40 mg furosemide-equivalent dose administered, was lower in patients with persistent or treatment-induced hyponatremia versus decompensation hyponatremia or no hyponatremia, respectively. The former versus latter groups also had more pronounced neurohumoral activation with decongestive treatment. The risk for all-cause mortality (hazard ratio, 2.50; 95% confidence interval, 1.50-4.19; P < .001) and death or heart failure readmission (hazard ratio, 2.18; 95% confidence interval, 1.60-2.97; P < .001) was significantly elevated in patients with persistent versus no hyponatremia, with the risk of decompensation and treatment hyponatremia situated in between.
  
  
  
  Transient hyponatremia is prognostically relevant, but it has a heterogeneous cause according to its temporal pattern of development.
authors.affiliation: Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Ohio; Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium; Doctoral School for Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
authors.forename: Frederik H
authors.initials: FH
authors.lastname: Verbrugge
authors.affiliation: Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Ohio.
authors.forename: Justin L
authors.initials: JL
authors.lastname: Grodin
authors.affiliation: Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium; Biomedical Research Institute, Department of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
authors.forename: Wilfried
authors.initials: W
authors.lastname: Mullens
authors.affiliation: Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Ohio.
authors.forename: David O
authors.initials: DO
authors.lastname: Taylor
authors.affiliation: Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Ohio.
authors.forename: Randall C
authors.initials: RC
authors.lastname: Starling
authors.affiliation: Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Ohio. Electronic address: tangw@ccf.org.
authors.forename: W H Wilson
authors.initials: WH
authors.lastname: Tang
mesh_terms: D000208:Acute Disease; D015415:Biomarkers / Q000097:blood; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000097:blood* / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology; D006801:Humans; D007010:Hyponatremia / Q000097:blood* / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016016:Proportional Hazards Models; D013997:Time Factors
chemical_list: D015415:Biomarkers; D004232:Diuretics
keywords: Diuretics; Heart failure; Prognosis; Sodium
references.citation: Eur Heart J. 2007 Apr;28(8):980-8
references.pmid: 17309900
references.citation: Rev Cardiovasc Med. 2006;7 Suppl 1:S12-24
references.pmid: 16955056
references.citation: JAMA. 2005 Feb 2;293(5):572-80
references.pmid: 15687312
references.citation: Am J Cardiol. 1983 Jun;51(10):1635-8
references.pmid: 6344606
references.citation: Am Heart J. 2001 Apr;141(4):528-35
references.pmid: 11275915
references.citation: J Am Coll Cardiol. 2015 Feb 10;65(5):480-92
references.pmid: 25660927
references.citation: Circ Heart Fail. 2014 Sep;7(5):766-72
references.pmid: 25037309
references.citation: Am J Cardiol. 2014 Jun 1;113(11):1834-8
references.pmid: 24837261
references.citation: Circ Heart Fail. 2013 May;6(3):379-86
references.pmid: 23512983
references.citation: Am J Cardiol. 2013 Apr 1;111(7):1019-25
references.pmid: 23312128
references.citation: Heart. 2012 Dec;98(24):1798-804
references.pmid: 23125248
references.citation: J Card Fail. 2012 Aug;18(8):620-5
references.pmid: 22858077
references.citation: Circ Heart Fail. 2011 Sep;4(5):637-43
references.pmid: 21673193
references.citation: N Engl J Med. 2011 Mar 3;364(9):797-805
references.pmid: 21366472
references.citation: Arch Intern Med. 2007 Oct 8;167(18):1998-2005
references.pmid: 17923601